October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...
SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received ...
In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, ...
SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ...
Improving patient understanding of GEP test results (IMPARTER4): An RCT. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Please provide your email address to receive an email when new articles are posted on . Results showed a lower 2-year cumulative rate of invasive ipsilateral breast cancer among patients assigned ...
Women with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring showed similar quality of life (QOL), anxiety levels, and symptom trajectories compared with those receiving surgery ...
Hi, I'm Eric Winer. I'm a medical oncologist who has focused on breast cancer my whole career, both taking care of patients and doing research related to breast cancer. There are approximately 60,000 ...
Cancer is typically treated with surgery, radiation and sometimes chemotherapy. But a new study suggests this standard protocol might not be necessary for a common form of early-stage breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results